Toggle light / dark theme

Dr. Robert Floyd, Ph.D. is Executive Secretary of the Comprehensive Nuclear-Test-Ban Treaty Organization (CTBTO — https://www.ctbto.org/), the organization tasked with building up the verification regime of the Comprehensive Nuclear-Test-Ban Treaty, a multilateral treaty opened for signature in 1996 by which states agree to ban all nuclear explosions in all environments, for military or civilian purposes.

Prior to joining CTBTO, Dr. Floyd was the Director General of the Australian Safeguards and Non-proliferation Office (ASNO), where he was responsible for Australia’s implementation of and compliance with various international treaties and conventions including the Comprehensive Nuclear-Test-Ban Treaty, Nuclear Non-Proliferation Treaty, Convention on the Physical Protection of Nuclear Material (CPPNM) and the Chemical Weapons Convention.

During his time as Director General of ASNO, Dr. Floyd also chaired the advisory group to the Director General of the International Atomic Energy Agency on safeguards implementation (SAGSI), co-chaired the Preparatory Committee for the review of the amended CPPNM, co-chaired one of the working groups of the International Partnership for Nuclear Disarmament Verification, was the lead official for Australia in the Nuclear Security Summit process, and chaired the Asia-Pacific Safeguards Network.

Prior to his appointment with ASNO, Dr. Floyd served for more than seven years in the Department of the Prime Minister and Cabinet where he held a number of senior executive positions providing advice to the Prime Minister on policy issues covering counter-terrorism, counter-proliferation, emergency management, and homeland and border security.

An older article but something the world is facing just like in certain sci-fi movies.


The reference publication of the movement in the 80s, the Earth First journal, featured a column called Ask Ned Ludd, in reference to the mythical character that gave name to the luddites. Jones thinks that neo-luddites are in fact misreading the original luddites, but he believes that understanding the difference between the old and modern ones tells us a lot about the ideology of the latter.

“Luddites were not anti-technology: they were skilled craftsmen, involved in a labour movement aimed at keeping their machines and their jobs,” he says. “That’s very different from the neo-luddites ideas of relinquishing civilisation and [of] nature as the supreme good.” Jones thinks neo-luddism is fed rather by “the idea of technology as a disembodied, transcendent, terrifying force outside the human”, which emerged in the mid 20th century, with the bomb and the rise of large-scale computing.

Is Director of the Division of Research, Innovation and Ventures (DRIVe — https://drive.hhs.gov/) at the Biomedical Advanced Research and Development Authority (https://aspr.hhs.gov/AboutASPR/ProgramOffices/BARDA/Pages/default.aspx), a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases.

Dr. Patel is committed to advancing high-impact science, building new products, and launching collaborative programs and initiatives with public and private organizations to advance human health and wellness. As the DRIVe Director, Dr. Patel leads a dynamic team built to tackle complex national health security threats by rapidly developing and deploying innovative technologies and approaches that draw from a broad range of disciplines.

Dr. Patel brings extensive experience in public-private partnerships to DRIVe. Prior to joining the DRIVe team, he served as the HHS Open Innovation Manager. In that role, he focused on advancing innovative policy and funding solutions to complex, long-standing problems in healthcare. During his tenure, he successfully built KidneyX, a public-private partnership to spur development of an artificial kidney, helped design and execute the Advancing American Kidney Health Initiative, designed to catalyze innovation, double the number of organs available for transplant, and shift the paradigm of kidney care to be patient-centric and preventative, and included a Presidential Executive Order signed in July 2019. He also created the largest public-facing open innovation program in the U.S. government with more than 190 competitions and $45 million in awards since 2011.

Prior to his tenure at HHS, Dr. Patel co-founded Omusono Labs, a 3D printing and prototyping services company based in Kampala, Uganda; served as a scientific analyst with Discovery Logic, (a Thomson Reuters company) a provider of systems, data, and analytics for real-time portfolio management; and was a Mirzayan Science and Technology Policy Fellow at The National Academies of Science, Engineering, and Medicine. He also served as a scientist at a nanotechnology startup, Kava Technology.

When a German security researcher, Matthias Marx, found a United States military device for sale on eBay—an instrument previously used to identify wanted individuals and known terrorists during the War in Afghanistan—Marx gambled a little and placed a low bid of $68.

He probably didn’t expect to win, since he offered less than half the seller’s asking price, $149.95. But win he did, and after that, he had an even bigger surprise coming, The New York Times reported. When the device arrived with a memory card still inside, Marx was shocked to realize he had unwittingly purchased the names, nationalities, photographs, fingerprints, and iris scans of 2,632 people whose biometric data had allegedly been scanned by US military.

The device allegedly stored not just personal identifiable information (PII) of seemingly suspicious persons, but also of US military members, people in Afghanistan who worked with the government, and ordinary people temporarily detained at military checkpoints. Most of the data came from residents of Afghanistan and Iraq.

Building A More Secure World — Dr. James Revill, Ph.D. — Head of Weapons of Mass Destruction & Space Security Programs, UNIDIR, UN Institute for Disarmament Research United Nations.


Dr. James Revill, Ph.D. (https://unidir.org/staff/james-revill) is the Head of the Weapons of Mass Destruction (WMD) and Space Security Program, at the UN Institute for Disarmament Research (UNIDIR).

Dr. Revill’s research interests focus on the evolution of the chemical and biological weapons and he has published widely in these areas. He was previously a Research Fellow with the Harvard Sussex Program at the Science Policy Research Unit, University of Sussex and completed research fellowships with the Landau Network Volta Center in Italy and the Bradford Disarmament Research Centre in the UK.

Maximizing Benefits Of The Life Sciences & Health Tech For All Americans — Dr. Andrew Hebbeler, Ph.D., Principal Assistant Director for Health and Life Sciences, Office of Science and Technology Policy, The White House.


Dr. Andrew Hebbeler, Ph.D., is Principal Assistant Director for Health and Life Sciences, Office of Science and Technology Policy at The White House (https://www.whitehouse.gov/ostp/ostps-teams/health-and-life-sciences/), and has extensive foreign affairs, national security, global health, and science and technology (S&T) policy experience.

Most recently, Dr. Hebbeler was Senior Director and Lead Scientist for Global Biological Policy and Programs at the non-profit Nuclear Threat Initiative and previous to that served in leadership positions at the State Department’s offices of Science and Technology Cooperation (OES/STC), the Science and Technology Adviser to the Secretary of State (E/STAS), and Cooperative Threat Reduction (ISN/CTR).